Manning Paul B's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Aug 16, 2023
- Accession no.
- 0001209191-23-046154
- Filed
- Aug 16, 2023
- Trade date
- Aug 16, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $14.8M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manning Paul BCIK 0001494695 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Common Stock | PPurchaseAcquired | +16,466,667 | $0.90 | +$14,820,000.3 | 16,466,667 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.